Christina Johansson

Title: Christina Johansson: Innovator in Pharmaceutical Composition

Introduction

Christina Johansson is a notable inventor based in Gothenburg, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. Her work focuses on improving the efficacy of treatments for serious lung diseases.

Latest Patents

Christina Johansson holds a patent for a delayed release composition for peroral administration. This pharmaceutical composition includes N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide (C21), or a pharmaceutically-acceptable salt thereof. The composition is designed to be protected by a coating comprising an enteric substance. Preferred dosage forms include capsules that present C21 or its salt in the form of a dry powder mixture or a suspension of particles in an insoluble solvent. This innovative approach is particularly useful in treating lung diseases such as idiopathic pulmonary fibrosis, sarcoidosis, and respiratory virus-induced tissue damage.

Career Highlights

Christina Johansson has established herself as a key figure in the pharmaceutical industry. Her work at Vicore Pharma AB has been instrumental in advancing therapeutic options for patients suffering from severe respiratory conditions. With her expertise, she continues to push the boundaries of pharmaceutical innovation.

Collaborations

Christina collaborates with Ola Camber, contributing to the development of groundbreaking pharmaceutical solutions. Their partnership exemplifies the importance of teamwork in driving innovation within the industry.

Conclusion

Christina Johansson's contributions to pharmaceutical compositions highlight her role as a leading inventor in the field. Her innovative approaches to drug delivery systems are paving the way for more effective treatments for lung diseases.